MX2011010961A - Formula en aspersion sublingual que comprende dihidroartemesinina. - Google Patents

Formula en aspersion sublingual que comprende dihidroartemesinina.

Info

Publication number
MX2011010961A
MX2011010961A MX2011010961A MX2011010961A MX2011010961A MX 2011010961 A MX2011010961 A MX 2011010961A MX 2011010961 A MX2011010961 A MX 2011010961A MX 2011010961 A MX2011010961 A MX 2011010961A MX 2011010961 A MX2011010961 A MX 2011010961A
Authority
MX
Mexico
Prior art keywords
sublingual
dihydroartemesinine
aspersion
formula
compositions
Prior art date
Application number
MX2011010961A
Other languages
English (en)
Spanish (es)
Inventor
Elizabeth Anita Ross
Original Assignee
Londonpharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0906971.7A external-priority patent/GB2469791B/en
Priority claimed from PCT/GB2009/050415 external-priority patent/WO2010122275A1/en
Application filed by Londonpharma Ltd filed Critical Londonpharma Ltd
Publication of MX2011010961A publication Critical patent/MX2011010961A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2011010961A 2009-04-23 2010-04-23 Formula en aspersion sublingual que comprende dihidroartemesinina. MX2011010961A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0906971.7A GB2469791B (en) 2009-04-23 2009-04-23 Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease
PCT/GB2009/050415 WO2010122275A1 (en) 2009-04-23 2009-04-23 Pharmaceutical preparation
PCT/GB2010/050672 WO2010122356A1 (en) 2009-04-23 2010-04-23 Sublingual spray formulation comprising dihydroartemesinin

Publications (1)

Publication Number Publication Date
MX2011010961A true MX2011010961A (es) 2012-04-20

Family

ID=42244197

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011010961A MX2011010961A (es) 2009-04-23 2010-04-23 Formula en aspersion sublingual que comprende dihidroartemesinina.

Country Status (23)

Country Link
US (4) US20120157518A1 (enExample)
EP (1) EP2424523B1 (enExample)
JP (1) JP5795760B2 (enExample)
CN (1) CN102395362B (enExample)
AU (1) AU2010240654C1 (enExample)
BR (1) BRPI1014887A8 (enExample)
CA (1) CA2756925A1 (enExample)
DK (1) DK2424523T3 (enExample)
ES (1) ES2390046T3 (enExample)
HR (1) HRP20120711T1 (enExample)
IL (1) IL215453A (enExample)
ME (1) ME02008B (enExample)
MX (1) MX2011010961A (enExample)
MY (1) MY155646A (enExample)
NZ (1) NZ595469A (enExample)
PL (1) PL2424523T3 (enExample)
PT (1) PT2424523E (enExample)
RS (1) RS52430B (enExample)
RU (1) RU2501550C2 (enExample)
SG (1) SG175162A1 (enExample)
SI (1) SI2424523T1 (enExample)
WO (1) WO2010122356A1 (enExample)
ZA (1) ZA201107088B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
JP2012524771A (ja) * 2009-04-23 2012-10-18 ロンドンファーマ リミテッド 中性油を含む舌下用の医薬組成物
EP2943193A2 (en) * 2013-01-14 2015-11-18 Health Clinics Limited Cancer drug and uses
WO2016083827A1 (en) 2014-11-27 2016-06-02 Cipla Limited Pharmaceutical composition comprising an artemisinin derivative for nasal or pulmonary delivery
JP2020033304A (ja) * 2018-08-30 2020-03-05 医療法人ふじいやさか 薬剤又はサプリメント、組成物、及び水素供給器の使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
CH692321A5 (de) * 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
HUP0102851A3 (en) * 1998-07-14 2003-03-28 Bayer Ag Antiparasitic artemisinin derivatives (endoperoxides), process for their preparation and pharmaceutical compositions containing them
AU2002219472A1 (en) * 2001-01-02 2002-07-16 Elisabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
MXPA04011808A (es) * 2002-05-31 2005-09-12 Univ Mississippi Liberacion transmucosica de canabinoides.
RU2004139090A (ru) * 2002-06-06 2005-06-10 Юниверсити Оф Вашингтон (Us) Способы применения соединений, подобных артемизинину, для профилактики или задержки возникновения злокачественных опухолей
WO2004075921A1 (en) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Inclusion complex of artemisinin or derivates thereof with cyclodextrins
US20060084675A1 (en) * 2004-10-18 2006-04-20 Thomas Efferth Combined treatment with artesunate and an epidermal growth factor receptor kinase inhibitor
US20060233895A1 (en) * 2005-04-15 2006-10-19 Brown Paul R Herbal remedy for treating Lyme disease
PT1933809E (pt) * 2005-10-11 2012-04-26 Yissum Res Dev Co Composições para administração por via nasal
CN100418524C (zh) * 2005-10-26 2008-09-17 重庆医药工业研究院有限责任公司 一种稳定的青蒿素及青蒿素衍生物的药物组合物

Also Published As

Publication number Publication date
NZ595469A (en) 2013-10-25
AU2010240654B2 (en) 2014-05-08
EP2424523A1 (en) 2012-03-07
SI2424523T1 (sl) 2012-11-30
CA2756925A1 (en) 2010-10-28
RU2501550C2 (ru) 2013-12-20
US20160022629A1 (en) 2016-01-28
IL215453A0 (en) 2011-12-29
SG175162A1 (en) 2011-11-28
HK1164140A1 (en) 2012-09-21
MY155646A (en) 2015-11-13
AU2010240654C1 (en) 2014-08-14
CN102395362B (zh) 2014-07-02
CN102395362A (zh) 2012-03-28
US20120157518A1 (en) 2012-06-21
AU2010240654A1 (en) 2011-10-20
HRP20120711T1 (hr) 2012-10-31
JP5795760B2 (ja) 2015-10-14
WO2010122356A1 (en) 2010-10-28
BRPI1014887A8 (pt) 2019-02-12
US20170368023A1 (en) 2017-12-28
BRPI1014887A2 (pt) 2016-04-19
PL2424523T3 (pl) 2012-11-30
RU2011139637A (ru) 2013-05-27
US20190142737A1 (en) 2019-05-16
DK2424523T3 (da) 2012-09-24
IL215453A (en) 2014-11-30
EP2424523B1 (en) 2012-06-27
JP2012524772A (ja) 2012-10-18
ES2390046T3 (es) 2012-11-06
ZA201107088B (en) 2012-12-27
PT2424523E (pt) 2012-10-03
RS52430B (sr) 2013-02-28
ME02008B (me) 2013-02-28

Similar Documents

Publication Publication Date Title
MX2010004392A (es) Composicion farmaceutica antimalarica.
MA32200B1 (fr) Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation
ECSP12011585A (es) Compuestos y composiciones para eltratamiento de enfermedades parasitarias
IN2012DN02805A (enExample)
PH12013501842A1 (en) Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
CO6341541A2 (es) Composiciones para el cuidado oral que comprenden capsulas
DOP2012000051A (es) Compuestos y composiciones como inhibidores de cinasa de proteina
CL2012001971A1 (es) Compuestos derivados de 1-piperazinil-3-piridin-carboxilato, como bloqueadores de los canales de sodio dependientes de voltaje; composicion farmaceutica; y su uso para el tratamiento de enfermedades respiratorias o del tracto respiratorio tal como asma, epoc, tos, silicosis, entre otras.
EA201201509A1 (ru) Фармацевтические составы, содержащие пиоглитазон и линаглиптин
PE20150998A1 (es) Inhibidores de histona demetilasas
CO6470821A2 (es) Pirazinilpirazoles
CR20110599A (es) Composiciones farmacéuticamente activas que comprenden moduladores de estrés oxidativo (osm), nuevas entidades químicas, composiciones y usos
SV2010003772A (es) Isoquinolinas e isoquinolinonas sustituidas en calidad de inhibidores de la rho-quinasa
UY32424A (es) Comprimidos conteniendo elivitegravir para tratamiento de infecciones virales
CO6710916A2 (es) Inhibidores de notum pectinacetilesterasa y métodos de su uso
CO6511222A2 (es) Derivado de idenona y composición famacéutica que comprende el mismo
UY29223A1 (es) Ácidos fenoxiacéticos sustituidos, composiciones farmacéuticas que los contienen y procesos para su preparación
UY29079A1 (es) Acidos fenoxiacéticos sustituidos, composiciones que los contienen, procedimientos de preparación y aplicaciones
CR9183A (es) Tiazolidinonas metasustituidas, su preparacion y su uso como medicamento
ECSP067019A (es) Compuestos y composiciones como moduladores del receptor activado por proliferador de peroxisoma (ppar)
MX2011010961A (es) Formula en aspersion sublingual que comprende dihidroartemesinina.
BR112015023878A2 (pt) composto, composição farmacêutica, e, uso de um composto
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
CO6321270A2 (es) Nuevas posibilidades de lucha contra la giardiasis
GT200900310A (es) Macrociclos y sus usos

Legal Events

Date Code Title Description
FG Grant or registration